Background and Purpose-Acute stroke patients with a large ischemic core may still benefit from mechanical thrombectomy (MT), but the predictors of clinical outcome are not well known after MT. We investigated the clinical and imaging factors associated with good outcome and mortality at 90 days in acute stroke patients with a large baseline ischemic core treated with MT. Methods-Data from the multicentric prospective ETIS (Endovascular Treatment in Ischemic Stroke) registry of consecutive acute ischemic stroke patients treated with MT from January 1, 2012, to August 31, 2016, were retrospectively analyzed. Baseline large ischemic core was defined as diffusion-weighted imaging (DWI)-Alberta Stroke Program Early CT Score of ≤5. The degree of disability was assessed by the modified Rankin Scale at 90 days. Outcomes included good outcome (modified Rankin Scale score of ≤2), and mortality (modified Rankin Scale score of 6). 
L arge baseline ischemic core acute stroke patients were excluded by the recent therapeutic trials demonstrating the clinical benefit of mechanical thrombectomy (MT). [1] [2] [3] The MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) failed to demonstrate an MT benefit in patients with a baseline Alberta Stroke Program Early CT (ASPECT) score of 0 to 4 (n=28), 4 while EXTEND-IA (Extending the Time for Thrombolysis in Emergency Neurological DeficitsIntra-Arterial), 5 SWIFT-PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment), 6 REVASCAT (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset), 7 and ESCAPE (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times) 8 trials specifically excluded patients on the basis of core extension, assessed either by ASPECT scores (using computed tomography or diffusion-weighted imaging [DWI] ) or by volumetric evaluation, because of previously reported evidence that DWI-positive lesion extension is a strong predictor of poor outcome, mortality, and hemorrhagic transformation. [9] [10] [11] [12] [13] [14] [15] Few studies have evaluated the impact of MT in this subset of stroke patients. [16] [17] [18] [19] [20] Even though they differed according to volume lesion assessment (computed tomography or magnetic resonance imaging) and cutoff value to define the large volume, recanalization status appeared to significantly impact outcome. Identifying clinical and imaging factors associated with a good outcome and mortality appears to be critical to avoid futile MT in this stroke population.
The aim of this study was to determine predictors of good outcome and mortality at 90 days in a multicenter prospective population of MT-treated stroke patients who had a large baseline ischemic core (DWI-ASPECT score of ≤5).
Methods
All data and materials have been made publicly available in a public repository and can be accessed by request from Dr Lapergue (b.lapergue@hopital-foch.org).
Study Population
Details regarding the ETIS (Endovascular Treatment in Ischemic Stroke) registry have been reported previously. 20 Briefly, ETIS was a prospective, multicenter, observational study of MT for acute ischemic stroke patients because of large vessel occlusion performed at 3 French comprehensive stroke centers treated within 8 hours of symptom onset. All consecutive anterior circulation stroke patients who had a large baseline ischemic core (DWI-ASPECT≤5) from January 1, 2012, to August 31, 2016, were treated and considered for the present study. The local ethics committees approved the use of patient data for this retrospective analysis. Details of the endovascular procedures have already been described. 21 
Study Variables and Outcome Definition
Patient demographics, main vascular risk factors, imaging findings, vital signs before MT, clinical severity of ischemic stroke, delay from symptom onset to neuroimaging, clinical outcomes, and hemorrhage development were recorded as baseline variables. Severity of the ischemic stroke was assessed using the National Institutes of Health Stroke Scale score at admission and 24 hours after MT. Time from symptoms onset to groin puncture and reperfusion, procedural complications, endovascular technique, and details of anesthesia were recorded. Collateral status, when the contralateral carotid artery and at least one vertebral artery were also catheterized, was defined using previously validated criteria according to the American Society of Intervention and Therapeutic Neuroradiology/ Society of Interventional Radiology or the Capillary Index Score (CIS). 22, 23 Results were dichotomized into favorable (American Society of Intervention and Therapeutic Neuroradiology/Society of Interventional Radiology grades 3-4) versus unfavorable (American Society of Intervention and Therapeutic Neuroradiology/Society of Interventional Radiology grades 0-2). DWI-ASPECT score on the pretreatment magnetic resonance imaging was evaluated prospectively, blinded to the results of the endovascular procedure and clinical outcome. Each Alberta Stroke Program Early CT Score region was scored 0 if abnormal and 1 if normal. To be considered as abnormal, the DWI hyperintense signal had to be confluent. A small hyperintense spot was not sufficient. Ischemic lesions were segmented semiautomatically with our own developed software after applying a threshold of apparent diffusion coefficient <615×10 −6 mm 2 /s on apparent diffusion coefficient maps. Arterial occlusion site and status were monitored with conventional angiography during the endovascular procedure.
Recanalization results were reported using the modified Thrombolysis in Cerebral Infarction (mTICI) grade and was assessed by a senior neurointerventionalist. Successful recanalization was defined as a final mTICI grade of 2b-3. All patients underwent computed tomography or magnetic resonance imaging 24 hours after MT to assess hemorrhagic complications. Trained research nurses unaware of the study group assignments assessed the modified Rankin Scale (mRS) at 90 days, during face-to-face interviews or via telephone conversations with the patient, their relatives, or their general practitioner. Good outcome was defined as mRS scores from 0 to 2 at 90 days.
Statistical Analysis
Quantitative variables are expressed as means±SD or medians (interquartile range), and categorical variables are expressed as numbers (percentage). Normality of distributions was assessed using histograms.
Bivariate comparisons between subgroups defined according to good outcome and 90-day mortality status were performed using the χ 2 test (or Fisher exact test when expected cell frequency is <5) for categorical variables or the Student t test (or MannWhitney U test in case of non-gaussian distribution) for quantitative variables. The primary aim of the present study was to define independent predictors of good outcome at 3 months (mRS score of 0-2). Secondary aim was to define independent predictors of 90-day mortality. Factors significantly affecting outcome (P<0.2) in bivariate analyses were entered into a binary logistic regression multivariable model for good outcome (mRS score of 0-2 versus 3-6) and for 3-month mortality after multiple imputation analysis. For the primary outcome (3-months follow-up mRS score of 0-2), 2 multivariable binary logistic regression models were produced: the first one only considered baseline, preprocedural features and the second included intervention-related variables. The reason for such a subdivision was to identify preprocedural outcome predictors to help the attending physician in the management process (choice of interventional therapy versus abstention). Subgroup analyses were performed for DWI lesion volume >70 mL and >100 mL population to identify independent predictors of 90-day good outcome (mRS score of 0-2) and mortality (mRS score of 6) in these subgroups.
Results of multivariable modeling were expressed as P for significance, odds ratio (OR), and 95% CI after adjustment for covariates, and scatter plots were constructed based on derived predicted probabilities of predefined outcomes. The Hosmer-Lemeshow test verified the appropriateness of the analysis. Multivariable analyses performed without multiple imputation as sensitivity analyses are reported in Tables I and II in the online-only Data Supplement. All statistical analysis was performed using SPSS version 20.0.
Results
Two hundred sixteen patients with a baseline ASPECT score of ≤5 (mean DWI volume 94±66.5 mL) treated with MT were included in the present study. Table 1 reports the baseline characteristics of study population. A total of 127 patients presented a DWI-positive lesional volume larger than 70 mL and 73, larger than 100 mL.
Results of bivariate analysis for factors associated with a good outcome and mortality at 90 days are presented in Table 2 . Results of bivariate analysis for factors associated with 90-day mortality are reported in Table I in the online-only Data Supplement. or death according to the baseline DWI lesional volume and recanalization status is reported in Figure. Results of bivariate analyses of factors associated with outcome for DWI volumes ≥70 and >100 mL subgroups are available in Table II and III in the online-only Data Supplement. 
Discussion
Our study provides important new data about the clinical outcome of stroke patients with a large baseline ischemic core treated with MT, along with its clinical and imaging predictors. Good outcome was achieved in 25.4% of overall population and in 31% of patients successfully recanalized (mTICI 2B-3) in line with previously reported results (21%-58%) [17] [18] [19] in large strokes, data confirmed by a recent HERMES meta-analysis where a significant treatment effect of endovascular treatment across ASPECT categories (7-5 and 4-0) was detected. 24 The main result of our study is that DWI lesional volume emerged to be the most reliable predictor in large strokes both from the preprocedural setting when the treating physician chooses whether to treat or not up to the postprocedural phase when predicting mortality. Moreover, it emerged as a stronger outcome predictor than DWI-ASPECT score. The potential limits of ASPECT score evaluation related to a wide range of lesion volume for each DWI-ASPECT point have been already reported. 25 Ischemic burden volume in the studied population seems to improve the limit of DWI-ASPECT score and to include the effect of collateral circulation: we found a strong correlation between DWI volume and collateral status (Mann-Whitney <0.001, data not shown). Interestingly, the importance of collateral status cannot be underestimated even in the large volume stroke setting. We looked for independent outcome predictors for patients affected by DWI-positive lesions larger than 70 and 100 mL, respectively, cutoffs which have been consistently shown to be associated with poor outcome and the so-called malignant profile. Few reports have suggested the well-known beneficial effect of collateral status to be effective even in the large volume stroke setting. 13, 14, 16, [26] [27] [28] Because of the large number of missing data regarding collateral status, we could not properly evaluate its effect in the studied population. Moreover, from the results of our study, successful recanalization ceased to be an independent outcome predictor in the population with DWI lesions larger than 100 mL. This could be due to the lack of greater granularity in the TICI grade assessment, 29 even though we have to acknowledge the progressive increase in number needed to treat associated with larger ischemic lesion volumes 30 . To the best of our knowledge, this is the largest reported series evaluating both DWI volume ischemic lesions on large volume stroke patients treated with MT. Unfortunately, we could not rule out sustained DWI reversal as a potential explanation of good outcome in this population due to the lack of uniform follow-up imaging. [31] [32] [33] Besides the importance of successful recanalization, age, and ischemic lesion burden, substantial consistency with available literature regarding critical factors in stroke management (eg, the effect of general anesthesia) emerges from our study. Nonetheless, they did not result in independent outcome predictors in the studied population. [16] [17] [18] [19] [20] [21] 34 In the available literature concerning MT for large volume stroke, rates of both symptomatic intracerebral hemorrhage or PH1-2 hemorrhage ranged from 16% to 31%. [16] [17] [18] [19] [20] [21] No significant difference emerged in our study between recanalized versus nonrecanalized patients and between ischemic core extension (Mann-Whitney 0.890 data not shown) and PH1-2 hemorrhagic transformation, in line with the results previously reported by Nogueira et al 19 and by Gilgen et al. 18 Nonetheless, the recently reported HERMES meta-analysis suggests an increased symptomatic hemorrhagic transformation rate in large volume stroke patients subjected to MT. 24 The impact of symptomatic hemorrhage in this population cannot be underestimated, and maximal effort should be devoted in properly defining its modifiable predictors. Worth mentioning, hemisphere location did not result as an independent outcome predictor in the studied population (global one and subpopulations), even though a statistically significant association was detected on bivariate analysis. This is consistent with multiple data sets and with the literature on decompressive craniectomy for the treatment of the malignant profile of middle cerebral artery occlusion. 13, 35, 36 Unfortunately, we lacked data regarding decompressive craniectomy rate in the studied population. This could be worth evaluating in future studies.
Strengths and Limitations
The strength of our study lies in the large sample of patients prospectively included in the ETIS registry, allowing a robust analysis of the predictors of clinical outcomes. However, the present study has several limitations, particularly those inherent to its retrospective design and registry status. Reported follow-up is relatively short (3 months). Even though it parallels the one including the 5 major randomized trials reported in 2015, we cannot exclude that a longer follow-up would probably have been more favorable to demonstrate the clinical outcome of the treated population, and so underestimating the overall mRS score of 0-2 observed. The lack of a greater granularity in the TICI grade (TICI grade of 2c) is a limitation of the present study. The gross TICI grade of 2B-3 data may have underestimated the impact of successful recanalization on the outcome of such a fragile population. The same goes 
